D. Medical, a medical device company that develops and manufactures insulin pumps, announced terms for its IPO on Wednesday. The Israel-based company plans to raise $30 million by offering 2.7 million shares at a price range of $10-$12. At the mid-point of the proposed range, D. Medical will command a market value of $98 million. D. Medical, which was founded in 1992 but has yet to book material sales, plans to list on the NASDAQ under the symbol DMED. Its shares are currently traded on the Tel-Aviv stock exchange under the ticker DMDC. Rodman & Renshaw and ThinkEquity are the lead underwriters on the deal, which is expected to price during the week of August 2.
